Ricardo Machado Xavier Selected Research

Ricardo Machado Xavier Research Topics

Disease

28	Rheumatoid Arthritis 11/2021 - 11/2005
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 04/2008
6	COVID-19 01/2022 - 01/2020
6	Systemic Scleroderma (Systemic Sclerosis) 10/2021 - 06/2010
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2017 - 11/2005
4	Rheumatic Diseases (Rheumatism) 10/2021 - 07/2011
4	Arthritis (Polyarthritis) 09/2017 - 11/2005
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 09/2011
3	Pain (Aches) 01/2021 - 05/2008
3	Inflammation (Inflammations) 01/2016 - 03/2010
2	Fatigue 04/2022 - 03/2018
2	Mucopolysaccharidosis I (Hurler Syndrome) 09/2018 - 09/2018
2	Fibromyalgia (Fibrositis) 01/2016 - 06/2009
2	Fibrosis (Cirrhosis) 01/2012 - 11/2009
2	Wounds and Injuries (Trauma) 04/2011 - 01/2011
2	Hypertension (High Blood Pressure) 06/2010 - 03/2010
2	Insulin Resistance 03/2010 - 09/2007
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Thromboembolism 01/2022
1	Lung Diseases (Lung Disease) 10/2021
1	Hypertrophy 01/2021
1	Osteoarthritis 01/2021
1	Psoriatic Arthritis 03/2019
1	Chronic Disease (Chronic Diseases) 03/2018
1	Body Weight (Weight, Body) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 01/2018
1	Atrophy 01/2018
1	Latent Tuberculosis 07/2015
1	Infections 07/2015
1	Synovitis 01/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
5	Pharmaceutical PreparationsIBA 01/2022 - 05/2018
5	ametantrone (HAQ)IBA 01/2021 - 05/2008
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2020
4	GlucocorticoidsIBA 10/2021 - 03/2006
4	CytokinesIBA 01/2021 - 09/2007
4	Complement System Proteins (Complement)IBA 09/2017 - 09/2011
3	Vitamin D FDA LinkGeneric 10/2020 - 10/2012
3	C-Reactive ProteinIBA 03/2018 - 05/2008
3	salicylhydroxamic acid (SHAM)IBA 01/2018 - 01/2011
3	AntibodiesIBA 01/2011 - 02/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2020
2	tocilizumab (atlizumab)FDA Link 01/2022 - 04/2017
2	Etanercept (Enbrel)FDA Link 01/2021 - 01/2019
2	KIR ReceptorsIBA 10/2020 - 07/2011
2	EnzymesIBA 09/2018 - 09/2014
2	CollagenIBA 01/2012 - 04/2011
2	HLA-G Antigens (HLA G)IBA 01/2012 - 05/2008
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2012 - 04/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011 - 01/2011
2	Anti-Citrullinated Protein AntibodiesIBA 11/2005 - 11/2005
1	Tocopherols (Tocopherol)IBA 04/2022
1	Urea (Carbamide)FDA LinkGeneric 04/2022
1	Lopinavir FDA Link 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	AnticoagulantsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Ritonavir (Norvir)FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 11/2021
1	Immunomodulating AgentsIBA 10/2021
1	Tumor Necrosis Factor InhibitorsIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	Prostaglandins AIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	SuspensionsIBA 01/2021
1	Protein Kinase InhibitorsIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	LipidsIBA 01/2020
1	N-phthaloylglutamic acidIBA 01/2020
1	Nucleic AcidsIBA 09/2018
1	GlycosaminoglycansIBA 09/2018
1	Iduronidase (alpha-L-Iduronidase)IBA 09/2018
1	milk-derived factorIBA 03/2018
1	MyostatinIBA 01/2018
1	MyogeninIBA 01/2018
1	Rituximab (Mabthera)FDA Link 09/2017
1	Gastrin-Releasing PeptideIBA 09/2017
1	Monoclonal AntibodiesIBA 04/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	tofacitinibIBA 11/2015
1	Antirheumatic Agents (DMARD)IBA 10/2015
1	Tuberculin (PPD)IBA 07/2015
1	Hormones (Hormone)IBA 07/2015
1	AutoantibodiesIBA 01/2015
1	TransferasesIBA 09/2014
1	Glutathione (Reduced Glutathione)IBA 09/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2012
1	Resistance Training 01/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Intranasal Administration 09/2018